odapipam has been researched along with amphetamine in 2 studies
Studies (odapipam) | Trials (odapipam) | Recent Studies (post-2010) (odapipam) | Studies (amphetamine) | Trials (amphetamine) | Recent Studies (post-2010) (amphetamine) |
---|---|---|---|---|---|
19 | 4 | 3 | 13,071 | 329 | 1,977 |
Protein | Taxonomy | odapipam (IC50) | amphetamine (IC50) |
---|---|---|---|
Phenylethanolamine N-methyltransferase | Bos taurus (cattle) | 0.96 | |
Cytochrome P450 2A6 | Homo sapiens (human) | 3.5 | |
Cytochrome P450 2A5 | Mus musculus (house mouse) | 2.85 | |
Sodium-dependent dopamine transporter | Rattus norvegicus (Norway rat) | 0.96 | |
Beta-2 adrenergic receptor | Cavia porcellus (domestic guinea pig) | 0.96 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gerlach, J; Hansen, L; Mørkeberg, F; Peacock, L | 1 |
Abi-Dargham, A; Anjilvel, S; Foged, C; Halldin, C; Hwang, DR; Kegeles, L; Laruelle, M; Lombardo, I; Mann, JJ; Parsey, R; Simpson, N; Van Heertum, R; Zea-Ponce, Y | 1 |
2 other study(ies) available for odapipam and amphetamine
Article | Year |
---|---|
Chronic dopamine D1, dopamine D2 and combined dopamine D1 and D2 antagonist treatment in Cebus apella monkeys: antiamphetamine effects and extrapyramidal side effects.
Topics: Amphetamine; Animals; Arousal; Basal Ganglia Diseases; Benzazepines; Benzofurans; Cebus; Dopamine Agents; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Drug Interactions; Dyskinesia, Drug-Induced; Dystonia; Male; Motor Activity; Raclopride; Receptors, Dopamine D1; Receptors, Dopamine D2; Salicylamides; Stereotyped Behavior | 1999 |
PET studies of binding competition between endogenous dopamine and the D1 radiotracer [11C]NNC 756.
Topics: Amphetamine; Animals; Benzazepines; Benzofurans; Binding, Competitive; Brain Chemistry; Carbon Radioisotopes; Cerebral Cortex; Corpus Striatum; Dopamine; Dopamine Agents; Dopamine Antagonists; Female; Magnetic Resonance Imaging; Male; Papio; Raclopride; Receptors, Dopamine D1; Salicylamides; Thalamus; Tomography, Emission-Computed | 1999 |